GenSight Biologics S.A. (EPA:SIGHT)

GenSight Biologics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	30	33	26	155	255	304
Market Cap Growth	28.79%	28.79%	-83.46%	-39.23%	-16.09%	275.09%
Enterprise Value	47	49	46	147	220	304
Last Close Price	0.24	0.27	0.46	3.36	5.56	7.13
PS Ratio	8.59	12.59	8.66	31.90	33.13	40.91
PB Ratio	-1.23	-1.23	-0.84	-10.16	15.97	25.91
P/TBV Ratio	-	-	-	-	16.09	26.20
EV/Sales Ratio	17.84	18.59	15.53	30.25	28.53	40.80
Debt / Equity Ratio	-0.71	-0.71	-0.77	-1.17	1.10	1.63
Asset Turnover	0.26	0.26	0.17	0.12	0.15	0.19
Quick Ratio	0.11	0.11	0.18	0.96	2.18	2.41
Current Ratio	0.24	0.24	0.26	1.57	2.40	2.56
Return on Equity (ROE)	-	-	-	-7781.69%	-206.34%	-305.52%
Return on Assets (ROA)	-99.39%	-99.39%	-105.83%	-42.13%	-33.80%	-39.03%
Return on Capital (ROIC)	-	-	-	-96.45%	-54.62%	-59.68%
Earnings Yield	-46.38%	-42.36%	-102.16%	-17.80%	-11.21%	-11.18%
FCF Yield	-39.14%	-39.14%	-96.14%	-21.91%	-6.72%	-4.95%
Buyback Yield / Dilution	-98.28%	-98.28%	-4.29%	-2.61%	-28.54%	-23.76%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.